Trial Outcomes & Findings for Phosphorous Magnetic Resonance Spectroscopy of Heart (NCT NCT01110395)
NCT ID: NCT01110395
Last Updated: 2020-08-07
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
15 participants
Primary outcome timeframe
1-2 days
Results posted on
2020-08-07
Participant Flow
Patients recruited from heart transplant clinic
Participant milestones
| Measure |
Transplant
Patients with post-OHT
|
|---|---|
|
Overall Study
STARTED
|
15
|
|
Overall Study
COMPLETED
|
15
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Phosphorous Magnetic Resonance Spectroscopy of Heart
Baseline characteristics by cohort
| Measure |
Heart Failure
n=15 Participants
Magnetic Resonance Spectroscopy
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=93 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
15 Participants
n=93 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=93 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=93 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=93 Participants
|
PRIMARY outcome
Timeframe: 1-2 daysOutcome measures
| Measure |
MR Spectroscopy Post-Heart Transplant
n=15 Participants
Patients post heart transplant getting heart biopsy
MR Spectroscopy: MR spectroscopy of myocardial
|
|---|---|
|
An MR Spectroscopy Showing Signal to Noise Ratio to Determine the Level of Heart Failure
|
7 Ratio
Standard Deviation 13.67
|
Adverse Events
Post-Heart Transplant
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory
Washington University School of Medicine
Phone: 314-747-3877
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place